EBO2-range protocols (20–30 gamma) and EBOO-range protocols (3–5 gamma) run on the same benchtop platform. The EBOO O3 Research Device 2026 is adjustable from 1–35 gamma and is supplied to qualified research institutions by written quote. Research and laboratory use only.
“EBO2 machine” is how the market describes an extracorporeal ozone research platform configured for higher-concentration, single-pass work — typically 20–30 gamma (µg/mL) — as opposed to EBOO-range operation at 3–5 gamma. The distinction is a concentration setting and protocol choice, not a different class of hardware. Both configurations move fluid through the same closed loop: pump section, PES H200 high-flux filter module, ozone contact stage, and return line.
The 2026 EBOO O3 Research Device is adjustable across 1–35 gamma, which spans EBOO-range protocols, EBO2-range protocols, and extended-range work on a single unit. Facilities that would otherwise buy two platforms — or rebuild a circuit between protocols — can standardize on one documented device with one equipment file.
EBO2-mode operation uses the same single-use disposables as EBOO-mode operation, so there is no separate “EBO2 filter” to source:
Browse all EBOO filters, lines and tubing, and complete kits. Verify luer-lock connector geometry before ordering; a free compatibility review is available on the compatibility page.
The EBOO O3 Research Device 2026 is supplied to qualified research institutions and professional laboratory facilities by written quote. There is no public list price. A quote sets out configuration, freight or white-glove delivery, lead time, and the procurement documentation your purchasing department needs, and is normally returned within one business day. Requesting a quote captures no payment.
For the wider evaluation checklist see the EBOO machine buyer guide, cost drivers in the price guide, and terminology in the EBOO vs EBO2 vs EBO3 comparison.
Research and laboratory use only. Not a medical device. Not FDA-cleared or approved for clinical, diagnostic, or therapeutic use.
In practice they describe operating modes rather than separate hardware. EBOO-range work runs at 3–5 gamma; EBO2-range work runs at 20–30 gamma. The EBOO O3 Research Device 2026 is adjustable from 1–35 gamma, so a single benchtop unit covers both configurations.
No. Both configurations use the same PES H200 high-flux filter module and the same luer-lock line sets. Concentration is a device setting, not a different disposable, so one consumable inventory serves both modes.
Request a written quote. The EBOO O3 Research Device 2026 has no public list price; a quote covers configuration, freight or white-glove delivery, lead time, and procurement documentation, and is normally issued within one business day. No payment is taken at quote request.
Circuit flow on the EBOO O3 Research Device 2026 is 2.5–5 L/hr with pump speed adjustable from 1 to 99, independent of the concentration setting. Flow and concentration are logged separately in per-run records.
No. The EBOO O3 Research Device 2026, in EBOO or EBO2 mode, is supplied for laboratory and research use only. It is not a medical device and is not cleared or approved by the U.S. FDA for clinical, diagnostic, or therapeutic use.
A detailed comparison of EBOO, EBO2, and EBO3 extracorporeal ozone devices covering performance, filter compatibility, specifications, and selection…
EBO2 lines are not a generic replacement item. The correct line set must match the device configuration, pump arrangement, filter connection style, and…
A missed filter match can stop a machine, delay scheduled work, and create a much bigger purchasing problem than the part cost suggests. That is why…